Tower Research Capital (TRC)’s Healthcare Triangle HCTI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.38K Buy
1,314
+520
+65% +$1.2K ﹤0.01% 4676
2026
Q1
$2.14K Buy
794
+762
+2,381% +$9.27K ﹤0.01% 4537
2025
Q4
$1.21K Buy
+32
New +$4.45K ﹤0.01% 4734
2025
Q3
– Hold
0
– -$130 – 5378
2025
Q2
– Hold
0
– – – 5130
2025
Q1
– Hold
0
– – – 4716
2024
Q4
– Sell
-1
Closed -$12.6K – 4568
2024
Q3
$4.63K Hold
1
– – ﹤0.01% 4469
2024
Q2
$4.88K Buy
+1
New +$15.5K ﹤0.01% 4736
2024
Q1
– Hold
0
– – – 4166
2023
Q4
– Hold
0
– – – 4460
2023
Q3
– Hold
0
– – – 4794
2023
Q2
– Hold
0
– – – 4621
2023
Q1
– Hold
0
– – – 4494
2022
Q4
– Hold
0
– – – 5009
2022
Q3
– Hold
0
– – – 4657
2022
Q2
– Hold
0
– – – 4676
2022
Q1
– Hold
0
– – – 5052
2021
Q4
– Hold
0
– – – 5028

Other funds holding HCTI

Tower Research Capital (TRC)'s HCTI Position: Q2 2026 in Review

Tower Research Capital (TRC) increased its Healthcare Triangle (HCTI) stake by 65% in Q2 2026, buying an estimated $1.2K and bringing the position to 1,314 shares worth $2.38K. The position accounts for ﹤0.01% of the portfolio, ranked #4676.

Tower Research Capital (TRC) first reported a position in HCTI in Q2 2024 and has held it in 5 quarters since. The position peaked at $4.88K in Q2 2024. 8 funds tracked by Wall St. Rank hold HCTI as of Q2 2026.

  • Tower Research Capital (TRC) held 1,314 shares of Healthcare Triangle worth $2.38K as of Q2 2026.
  • Tower Research Capital (TRC) bought 520 Healthcare Triangle shares in Q2 2026, an estimated $1.2K.
  • Healthcare Triangle made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #4676 holding.
  • Tower Research Capital (TRC) first reported a position in Healthcare Triangle in Q2 2024 and has held it in 5 quarters since.
  • Tower Research Capital (TRC)'s Healthcare Triangle position peaked at $4.88K in Q2 2024.
  • 8 funds tracked by Wall St. Rank held Healthcare Triangle as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.